Streetbeat News

Products Services

DV

DoubleVerify (DV) has expanded its AI-powered brand safety and suitability capabilities for TikTok advertisers by introducing 16 new content categories. This expansion supports TikTok's Inventory Filters - Vertical Sensitivity and Category Exclusion, enhancing advertisers' ability to align their promotions with suitable content. DV's Universal Content Intelligence, leveraging AI technology, powers this expansion, offering precise content classification across various sectors. This move is part of DV's ongoing partnership with TikTok, aimed at ensuring brand equity protection and maximizing campaign effectiveness.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:36 pm

FBLG

FibroBiologics, Inc. (NASDAQ:FBLG) has been granted a patent by the Australian Patent Office for a proprietary method using a cellular blend for the regeneration of cartilage-type cells. This technology, focusing on fibroblast cell-based solutions, aims to address chronic diseases by regenerating cartilage tissue, offering potential treatments for conditions that lead to pain, inflammation, and loss of joint function. The company, with over 150 patents issued and pending, emphasizes the novelty and utility of their method in fibroblast cell therapy and regenerative medicine.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:32 pm

BABA

CGRO

PDD

PGJ

Alibaba Group Holding Limited (NYSE:BABA) stock is on the rise following a report of co-founder Jack Ma supporting the company's restructuring and focus on AI technology to compete with PDD Holdings Inc (NASDAQ:PDD). Alibaba Cloud is offering significant discounts to international clients and plans to extend its AI platform to Singapore. The stock has fallen over 25% in the past year but saw a slight increase in premarket trading. Exposure to Alibaba stock can also be gained through Invesco Golden Dragon China ETF (NASDAQ:PGJ) and Tidal Trust II CoreValues Alpha Greater China Growth ETF (NYSE:CGRO).

Portfolio Pulse from Anusuya Lahiri

April 11, 2024 | 1:30 pm

JNJ

RLYB

Rallybio Corporation (RLYB) announced a collaboration with Johnson & Johnson (JNJ) to develop therapies for fetal and neonatal alloimmune thrombocytopenia (FNAIT), including a $6.6 million equity investment from JNJ. Rallybio's RLYB212, aimed at preventing FNAIT, is advancing to a Phase 2 study in H2 2024. JNJ is also conducting a Phase 3 study on nipocalimab for FNAIT. RLYB shares surged 106.10% to $3.38.

Portfolio Pulse from Vandana Singh

April 11, 2024 | 1:27 pm

RVSN

Rail Vision Ltd (NASDAQ:RVSN) has received an initial $1 million purchase order from a U.S.-based rail and leasing services company, as part of a contract that could total up to $5 million. The order is for Rail Vision's AI-based ShuntingYard products, set to be installed in Q3 of this year. This marks a significant step in Rail Vision's expansion in the U.S. market, with potential for up to $4 million in additional orders under the contract.

Portfolio Pulse from Adam Eckert

April 11, 2024 | 1:26 pm

NVEI

Nuvei Corporation (NASDAQ:NVEI) announced the launch of its Invoice Financing services, integrated into leading ERP platforms like Sage and Acumatica. This service aims to optimize cash flow for merchants by allowing them to access funds from customer invoices within 24 hours. The solution is part of Nuvei's Accounts Receivable Automation suite, designed to improve Days Sales Outstanding (DSO) and provide financial flexibility during periods of high interest rates. Nuvei's Invoice Financing offers instant access to capital, enhanced cash flow management, and seamless integration with existing workflows.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:15 pm

WAVE

Eco Wave Power Global AB (NASDAQ:WAVE) has signed a contract with an unnamed major energy company to develop the first US wave energy pilot station at AltaSea's premises in the Port of Los Angeles. This follows a comprehensive feasibility study identifying 77 potential sites in the US for Eco Wave Power's technology. The initiative aligns with efforts to meet net-zero goals and marks a significant step in the US's adoption of wave energy, supported by legislation in California and potential legislation in New Jersey.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:15 pm

ENLV

Enlivex shares are trading lower following the announcement of topline results from its Phase II trial evaluating Allocetra in sepsis.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:08 pm

AZN

FUSN

AstraZeneca Plc (NASDAQ:AZN) announced a 7% increase in its annual dividend to $3.10 per share for 2024, signaling confidence in its financial health and future performance. This decision comes ahead of a shareholder vote on CEO Pascal Soriot's pay package, which could see an increase of £1.8 million. The company also highlighted its acquisition of Fusion Pharmaceuticals Inc (NASDAQ:FUSN) for $21.00 per share plus a contingent value right. AstraZeneca expects a low double-digit to low teens percentage increase in total revenues and core EPS for fiscal year 2024. Additionally, the FDA approved AstraZeneca's Fasenra for severe asthma in younger patients.

Portfolio Pulse from Vandana Singh

April 11, 2024 | 1:04 pm

SGBX

Safe & Green Holdings Corp. (NASDAQ:SGBX) has entered into a design/build agreement with Talent Services LLC for the design and production of eight modular units that meet the Department of Energy's Net-Zero Energy Ready Requirements. These units, ranging from one to three bedrooms, are expected to be delivered in North Carolina by Q4 2024. This project, potentially expanding to 600 units over seven years, aligns with Safe & Green's commitment to sustainable, modular construction.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:02 pm